Nov 2, 4:35 PM ET
HealthStream reported third quarter 2026 revenue of $83.3 million, up 8.9%, while net income fell 11.7% to $5.4 million and diluted EPS fell to $0.18 from $0.20. The company raised its full-year 2026 revenue, net income and adjusted EBITDA guidance, and declared a $0.035 quarterly dividend.
- Q3 2026 revenue $83.3 million, up 8.9% from $76.5 million; operating income $6.6 million, down 13.0%
- Q3 net income $5.4 million, down 11.7%; diluted EPS $0.18 versus $0.20; adjusted EBITDA $19.3 million, up 1.0%
- 2026 guidance raised: revenue $331.0 million to $333.0 million; net income $21.8 million to $22.4 million; adjusted EBITDA $77.0 million to $78.0 million
- Quarterly dividend of $0.035 per share payable November 27, 2026 to holders of record on November 16, 2026
Read the filing on SEC.gov ↗
Sep 23, 4:15 PM ET
HealthStream's Compensation Committee approved special grants of time-based and performance-based restricted share units to its named executive officers on September 18, 2026, under its shareholder-approved 2022 Omnibus Incentive Plan. The grants are meant to encourage future performance and retention, and they add to the equity compensation of these officers.
- Four named executive officers (Robert A. Frist, Jr., Michael M. Collier, Trisha L. Coady, Kevin P. O'Hara) each received 15,395 time-based RSUs with a grant date fair value of $450,000, plus 5,132 performance-based RSUs valued at $150,000 e
- Scott A. Roberts received 12,316 time-based RSUs valued at $360,000 and 4,105 performance-based RSUs valued at $120,000.
- Time-based RSUs vest in equal annual 25% installments over four years from the grant date.
- Performance-based RSUs vest in 25% increments tied to annual targets for 2027 through 2030, to be set by the Committee.
Read the filing on SEC.gov ↗
Sep 15, 9:27 AM ET
HealthStream issued 1,355,932 new shares to WJRJJ Ventures, LLC for about $40 million, and CEO Robert A. Frist, Jr. sold the investor 144,068 existing shares for about $4.25 million, both at $29.50 per share; the transaction closed September 14, 2026. The issuance increases the number of shares outstanding, and the company intends to use the net proceeds for general corporate purposes, including investment in its solutions, working capital and potential acquisitions. Because WJRJJ's owner has ties to Empath Nursing, a company in which HealthStream holds about 5%, the deal was approved by the audit committee and disinterested directors.
- Company issued 1,355,932 new common shares at $29.50 each for about $40 million in cash, closing September 14, 2026.
- CEO Robert A. Frist, Jr. sold 144,068 existing shares to WJRJJ Ventures for about $4.25 million at $29.50 per share.
- Related-party link: WJRJJ owns about 42% of Empath Nursing, and HealthStream holds about 5% of Empath; the audit committee approved the deal and Mr. Frist abstained.
- The investor is subject to standstill obligations for 12 months, and a registration rights agreement covers resale of the shares, with filing due within 45 days of an investor request.
Read the filing on SEC.gov ↗
Sep 14, 9:21 AM ET
HealthStream entered into a Second Amendment to its revolving credit agreement with Truist Bank as administrative agent, keeping the $50 million facility on terms consistent with the prior agreement. The amendment extends the facility's maturity to September 10, 2031 and sets initial interest margins and a commitment fee, giving the company continued access to revolving credit under unsecured terms.
- Revolving loans up to $50 million, with $5 million sublimits for swingline loans and standby letters of credit
- Credit facility matures September 10, 2031; the company can seek to increase availability by up to $25 million, subject to lender commitments
- Initial applicable margins of 0.50% for base rate loans and 1.50% for SOFR loans; initial commitment fee of 20 basis points per annum
- Financial covenants require a net funded debt leverage ratio of not more than 3.00 to 1.00 and an interest coverage ratio of not less than 3.00 to 1.00
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
